Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Votrient in Second-line Advanced Renal Cell Carcinoma
NCT01577784Phase 2Unknown
- Sponsor
- Associació Per la Recerca Oncològica
- Start
- Apr 2012
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in renal cell carcinoma (RCC), sponsored by Associació Per la Recerca Oncològica. Status: unknown.
02
Drugs
pazopanib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT01577784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01577784.